- Home
- TENX vs NNVC Comparison
TENX vs NNVC Comparison
Compare TENX & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- NNVC
- Stock Information
- Founded
- TENX 1967
- NNVC 2005
- Country
- TENX United States
- NNVC United States
- Employees
- TENX N/A
- NNVC N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- TENX Health Care
- NNVC Health Care
- Exchange
- TENX Nasdaq
- NNVC Nasdaq
- Market Cap
- TENX 19.5M
- NNVC 21.2M
- IPO Year
- TENX N/A
- NNVC N/A
- Fundamental
- Price
- TENX $5.52
- NNVC $1.47
- Analyst Decision
- TENX Strong Buy
- NNVC Strong Buy
- Analyst Count
- TENX 4
- NNVC 1
- Target Price
- TENX $20.67
- NNVC $6.50
- AVG Volume (30 Days)
- TENX 67.4K
- NNVC 167.5K
- Earning Date
- TENX 11-13-2024
- NNVC 02-12-2025
- Dividend Yield
- TENX N/A
- NNVC N/A
- EPS Growth
- TENX N/A
- NNVC N/A
- EPS
- TENX N/A
- NNVC N/A
- Revenue
- TENX N/A
- NNVC N/A
- Revenue This Year
- TENX N/A
- NNVC N/A
- Revenue Next Year
- TENX N/A
- NNVC N/A
- P/E Ratio
- TENX N/A
- NNVC N/A
- Revenue Growth
- TENX N/A
- NNVC N/A
- 52 Week Low
- TENX $2.77
- NNVC $1.00
- 52 Week High
- TENX $27.36
- NNVC $3.59
- Technical
- Relative Strength Index (RSI)
- TENX 52.17
- NNVC 60.22
- Support Level
- TENX $5.70
- NNVC $1.42
- Resistance Level
- TENX $6.01
- NNVC $1.57
- Average True Range (ATR)
- TENX 0.48
- NNVC 0.07
- MACD
- TENX -0.06
- NNVC 0.01
- Stochastic Oscillator
- TENX 17.65
- NNVC 83.33
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.